Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
The myth of “leaner and meaner” pharma
Endpoints
Thu, 06/15/17 - 05:42 pm
layoffs
hirings
R&D
staff
employees
Big Pharma
Keytruda bonanza inspires a facelift and plans to invest more than $600M in translational research
Endpoints
Thu, 06/15/17 - 09:37 am
Keytruda
Merck
R&D
LifeArc
Gaining the Competitive Advantage in Pharma
Elsevier
Wed, 06/14/17 - 11:48 am
R&D
drug development
competition
Former Pfizer Scientist Is Resurrecting Projects To Solve The Multidrug Resistant Bacteria Problem
Forbes
Tue, 06/13/17 - 10:28 am
Pfizer
antibiotic resistance
R&D
9 Biotech Stats That Will Blow You Away
Motley Fool
Mon, 06/12/17 - 10:13 pm
biotech
drug development
R&D
drug approvals
Endocyte slumps on staff and R&D cuts
BioPharma Dive
Wed, 06/7/17 - 10:06 am
Endocyte
layoffs
R&D
How Did Bristol Lose An Edge In Lung Cancer? It's No Mystery, Says New R&D Boss
Forbes
Sat, 06/3/17 - 09:28 am
Bristol-Myers Squibb
lung cancer
R&D
Opdivo
Merck
Keytruda
Endocyte slashes staff and retrenches in the wake of back-to-back R&D setbacks
Endpoints
Fri, 06/2/17 - 10:42 am
Endocyte
layoffs
R&D
EC1456
New report heralds a revolution in cancer R&D trends – and the sticker shock that comes with it
Endpoints
Thu, 06/1/17 - 09:02 am
cancer
R&D
drug development
Industry Pulse: R&D spending in charts
BioPharma Dive
Mon, 05/29/17 - 11:51 am
R&D
Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau
Endpoints
Thu, 05/25/17 - 09:14 am
Merck
Neuroscience
anti-tau antibodies
R&D
drug development
Pharma’s Identity Crisis: Four strategies for creating value in life sciences
Pharmafile
Sat, 05/20/17 - 01:23 pm
pharma industry
R&D
M&A
competition
Novartis is sending 500 jobs to the scrap heap while adding 350 ‘high-tech’ positions for growth
Endpoints
Thu, 05/18/17 - 07:56 pm
Novartis
layoffs
R&D
Heptares nabs $5M from Teva for new migraine molecule
Fierce Biotech
Thu, 05/18/17 - 10:09 am
Heptares Therapeutics
R&D
drug development
migraines
Teva Pharmaceutical
She’s got a radical approach for the age of superbugs: Don’t fight infections. Learn to live with them
Stat
Thu, 05/18/17 - 09:42 am
Salk Institute
R&D
drug development
superbugs
Cloud-based Biotech: Managing Data for All Stages of Drug Development
Xtalks
Tue, 05/16/17 - 10:36 pm
drug development
R&D
biotech
the cloud
Pharma's Not So Stingy With R&D After All
Forbes
Mon, 05/15/17 - 09:42 am
R&D
pharma industry
PhRMA ousts 22 drugmakers from ranks in membership change
BioPharma Dive
Thu, 05/11/17 - 11:18 am
PhRMA
R&D
Novartis pushes further into pain with Durect deal
BioPharma Dive
Tue, 05/9/17 - 10:45 pm
Novartis
Durect
Sandoz
biosimilars
generics
Posimir
R&D
Takeda pens GammaDelta Therapeutics $100M pact, with M&A option
Fierce Biotech
Tue, 05/9/17 - 10:21 am
Takeda
GammaDelta Therapeutics
M&A
R&D
gamma delta T cells
Pages
« first
‹ previous
…
41
42
43
44
45
46
47
48
49
…
next ›
last »